Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
1 other identifier
interventional
16
1 country
2
Brief Summary
The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable major-depressive-disorder
Started Dec 2024
Shorter than P25 for not_applicable major-depressive-disorder
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2024
CompletedFirst Posted
Study publicly available on registry
November 19, 2024
CompletedStudy Start
First participant enrolled
December 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedJanuary 9, 2025
January 1, 2025
2 months
November 9, 2024
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Enrollment rate
This is defined as the number enrolled divided by the number of eligible participants screened
post intervention (14 weeks after baseline)
Retention rate
This is defined as the number completing the study/number enrolled at baseline
post intervention (14 weeks after baseline)
Session attendance rate (proportion of sessions attended)
post intervention (14 weeks after baseline)
Homework completion rate (proportion of homework assignments completed)
post intervention (14 weeks after baseline)
User satisfaction as assessed by The Participant Satisfaction Survey
This is a 16 item questionnaire and the first 10 questions are scored from 1( strongly disagree)to 5(strongly agree) for a maximum score of 50, higher score indicating better outcome
post intervention (14 weeks after baseline)
Secondary Outcomes (4)
Change in depression as assessed by the Patient Health Questionnaire-9 (PHQ-9),
baseline, end of session 12 (12 weeks form baseline)
Change in quality of Life as assessed by the Quality of Life in Epilepsy Inventory-10 (QOLIE-10)
baseline, end of session 12(12 weeks form baseline)
Change resilience as assessed by the Connor-Davidson Resilience Scale (CD-RISC)
baseline, end of session 12(12 weeks form baseline)
Change in efficacy in the self management of epilepsy as assessed by the Epilepsy Self-Efficacy Scale (ESES)
baseline, end of session 12(12 weeks form baseline)
Study Arms (1)
Neurobehavioral therapy
EXPERIMENTALInterventions
Participants will receive an introduction session and 12 1-hour long online sessions once per week for a total of 12 weeks that are guided by the investigator who is trained in NBT.Participants will engage in tools to aid in assuming control over their seizures; contextualize their environment; identify moods, situations, and thoughts; train healthy communication and support seeking; understand central nervous system medications and seizures; conduct a functional behavioral analysis; learn relaxation techniques; examine external stressors and internal triggers; and prepare for life after the intervention. Participants will be asked to complete weekly homework, thought records, seizure logs that are found in their workbooks and to engage in journal entries.
Eligibility Criteria
You may qualify if:
- English speaking veterans
- has home internet access
- has access to and familiarity in using a computer or tablet at least weekly
- Asymptomatic patients with chronic conditions
- has access to a mobile device with Short Message Service (SMS) text and picture capability
- has an active clinical diagnosis of major depressive disorder based on the International Classification of Diseases, 10th version (ICD-10)
- has an ICD-10 diagnosis of epilepsy with at least one seizure documented within the last five years
You may not qualify if:
- pregnancy
- Veterans that have current suicidal ideation
- have active psychosis; and have an ICD-10 diagnosis of psychogenic non-epileptic seizures or conversion disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030, United States
The University of Texas health Science Center at Houston
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa Fadipe, MSN, APRN, FNP-C
The University of Texas Health Science Center, Houston
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Student
Study Record Dates
First Submitted
November 9, 2024
First Posted
November 19, 2024
Study Start
December 19, 2024
Primary Completion
February 6, 2025
Study Completion
April 1, 2025
Last Updated
January 9, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share